![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 39/015 | |
C07K 14/78 | |||
C07K 16/20 | |||
C12N 15/86 | |||
A61K 39/39 | |||
C07K 14/445 |
(11) | Number of the document | 2160197 |
(13) | Kind of document | T |
(96) | European patent application number | 08736880.9 |
Date of filing the European patent application | 2008-04-10 | |
(97) | Date of publication of the European application | 2010-03-10 |
(45) | Date of publication and mention of the grant of the patent | 2016-09-21 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/GB2008/001175 |
Date | 2008-04-10 |
(87) | Number | WO 2008/122769 |
Date | 2008-10-16 |
(30) | Number | Date | Country code |
0706914 | 2007-04-10 | GB | |
0717888 | 2007-09-13 | GB |
(72) |
REYES, Arturo, GB
HILL, Adrian, GB
O`HARA, Geraldine, GB
COLLOCA, Stefano, IT
CORTESE, Riccardo, IT
|
(73) |
GlaxoSmithKline Biologicals SA,
Rue de l`Institut 89, 1330 Rixensart,
BE
Oxford University Innovation Limited, Buxton Court 3 West Way Botley, Oxford OX2 0SZ, GB |
(54) | ADENOVIRAL VECTOR ENCODING MALARIA ANTIGEN |
ADENOVIRAL VECTOR ENCODING MALARIA ANTIGEN |